Search

Your search keyword '"Allen, Steven L."' showing total 859 results

Search Constraints

Start Over You searched for: Author "Allen, Steven L." Remove constraint Author: "Allen, Steven L."
859 results on '"Allen, Steven L."'

Search Results

3. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

4. The Planet as Exoplanet Analog Spectrograph (PEAS): Design and First-Light

5. Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells

6. Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL

7. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

11. Representations of Time Coordinates in FITS

12. The Colloquium on Decoupling Civil Timekeeping from Earth Rotation

13. W. M. Keck observatory instrumentation status and future direction

14. Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli

15. The DEIMOS spectrograph for the Keck II Telescope: integration and testing

16. Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.

18. Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors

19. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

20. Integrin Signaling Pathway Is Crucial for the Recently Divided Fraction of CLL Cells and Facilitates Cell Migration in a Disease Progressive Manner

21. Whole Genome Sequencing Comparison of Acute Myeloid Leukemia at Presentation and Remission Predicts Patient Outcome

22. CD8+ T Cells from Patients with CLL Show Evidence of Granzyme B and Perforin Cytotoxic Capacity, Which Is Enhanced upon Exposure to Exogenous IL2 and/or IL21

23. Identification of Three Unique Clusters of Serum Proteins with Distinctive Functionalities in IGHV-Mutated MBL

28. IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

30. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes

32. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

33. Activated CLL cells regulate IL-17F–producing Th17 cells in miR155-dependent and outcome-specific manners

35. Joint special operations forces logistics talent management

37. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

38. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease

39. P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

43. Serum Proteomic Analyses Suggest That the HMGB1 and Other Inflammatory Pathways Are Operational in MBL and Are Less in Overt CLL

44. Analyses of the Kinetics and Phenotype of Multiple Intraclonal CXCR4/CD5 B Cell Subsets Suggest Differences in Life Cycle Transitioning in CLL

48. Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data

49. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)

Catalog

Books, media, physical & digital resources